flanders.bio's Healthcare Leaders Dinner

flanders.bio and KBC Securities will be organising - for the 4th time - an exclusive CEO Dinner with the listed Belgian biotech companies. During this high level dinner we will welcome the CEO’s of a select group of Belgian biopharma companies to openly discuss common topics that are important for our sector: financing of innovation, initiatives from and towards the government related to our sector, collaborations between all stakeholders involved, etc and to see where we can play a facilitating role.

The following CEO's confirmed their participation:

  • Edwin Moses, Ablynx
  • Tim Van Hauwermeiren, argenx
  • Herman Verrelst, Biocartis
  • Thomas Lienard, Bone Therapeutics
  • Christian Homsy, Celyad
  • Dirk Reyn, eTheRNA immunotherapies NV
  • Onno Van de Stolpe, Galapagos
  • Stef Heylen, Janssen Pharmaceutica
  • Jan Groen, MDxHealth
  • Francois Fornieri, Mithra
  • Patrik De Haes, ThromboGenics
  • Eduardo Bravo, TiGeniX

Event Details

Date:

Monday, December 11, 2017 (19:00 h - 22:00 h)

Location:

KBC Securities, Grote Markt, Brussel

Price:

FLANDERS.BIO MEMBER BENEFIT: This is an on-invitation-only event- exclusively for flanders.bio members

Language:

English

More info?

For any further information about this event, please do not hesitate to get in touch with our Communications Coordinator

Alternate Text

Jonas De Backer

Communications Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?